Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- HUGE
- Price
- 5.39
- Stock movement up
- +0.59 (12.29%)
- Company name
- FSD Pharma Inc Class B
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 3.82M
- Ent value
- 5.56M
- Price/Sales
- -
- Price/Book
- 0.37
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -30.17%
- 1 year return
- -92.97%
- 3 year return
- -61.73%
- 5 year return
- -62.41%
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
HUGE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.37 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 708.61K |
| EPS (TTM) | -10.23 |
| FCF per share (TTM) | -5.57 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -264.55K |
| Operating income (TTM) | -10.93M |
| Net income (TTM) | -7.46M |
| EPS (TTM) | -10.23 |
| EPS (1y forward) | -0.12 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 3.31M |
| Net receivables | 0.00 |
| Total current assets | 10.02M |
| Goodwill | 0.00 |
| Intangible assets | 5.15M |
| Property, plant and equipment | 73.12K |
| Total assets | 15.25M |
| Accounts payable | 3.60M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 5.04M |
| Total liabilities | 5.04M |
| Shareholder's equity | 10.20M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -5.14M |
| Capital expenditures (TTM) | 43.00 |
| Free cash flow (TTM) | -4.06M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -73.13% |
| Return on Assets | -48.94% |
| Return on Invested Capital | -73.13% |
| Cash Return on Invested Capital | -39.79% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 4.71 |
| Daily high | 5.45 |
| Daily low | 4.60 |
| Daily Volume | 194K |
| All-time high | 9080.17 |
| 1y analyst estimate | 2.60 |
| Beta | 0.85 |
| EPS (TTM) | -10.23 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 12 May 2025 |
Downside potential
Loading...
Downside potential data
| HUGE | S&P500 | |
| Current price drop from All-time high | -99.94% | -0.35% |
| Highest price drop | -99.96% | -56.47% |
| Date of highest drop | 3 Sep 2024 | 9 Mar 2009 |
| Avg drop from high | -90.15% | -11.07% |
| Avg time to new high | 100 days | 12 days |
| Max time to new high | 1524 days | 1805 days |
COMPANY DETAILS
Marketcap
3.82M
Marketcap category
Small-cap
Description
FSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc. is headquartered in Toronto, Canada.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Raza Bokhari
Country
USA
City
Cobourg
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner